The U.S. government will pay the vaccine maker Moderna $176 million to develop a pandemic vaccine that could be used to treat bird flu in people as cases in dairy cows continue to mount across the country, federal officials announced Tuesday.
The funds are targeted for release through the U.S. Department of Health and Human Services and will pay for continued development of a vaccine that uses the same mRNA technology that allowed rapid development and rollout of vaccines to protect against COVID-19. The award was made through the Biomedical Advanced Research and Development Authority, or BARDA, a program that focuses on medical treatments for potential pandemics.
Moderna will launch trials to test the safety and effectiveness of a vaccine that could be used to scale up a response to a bird flu pandemic, if needed.
The H5N1 virus was detected earlier this year in dairy cows and has spread to more than 135 herds in 12 states and infected three people to date, all with mild cases. Federal health officials stress that the risk to the wider population remains low.
__
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Science and Educational Media Group. The AP is solely responsible for all content.
![Hormel headquarters in Austin, MN. ] GLEN STUBBE * gstubbe@startribune.com Friday September 11, 2015 Despite woes throughout the food industry, partly due to consumers turning away some from processed foods, Hormel has managed to continue prospering -- even though a good part of its business -- Spam, chili -- is about as processed as you can get. But the company's turkey and pork offerings are riding a hot protein trend. And over the past two years, it's made some of the biggest acquisitions in](https://arc.stimg.co/startribunemedia/527MWWMEXAN6BDVVGMMGBOERGU.jpg?&w=252&ar=3:2&fit=crop)